Coimbra’s HospitalSLEhydroxychloroquinePDNprednisolone
…ling 2019 EULAR/ACR or 2012 SLICC criteria for SLE, followed at Coimbra’s Hospital. Data were obtained from the prospective clinical registry.Elig…
11,350articles mentioning institutions
22,378institution mentions
9,137distinct institutions extracted
0%of mentions human-reviewed
All extracted institutions
Showing 1,981–2,040 of 9,137, ordered by supporting articles. Choose a institution to see its evidence.
A&E1ACCORD1ADSTILADRIN1AGENAS1AGU1AIC Kijabe Hospital1AKUH1ALERT Comprehensive Specialised Hospital1ALSWH1AMBOSS1ANRS-PREVENIR1ANZCRT1APPAC IV1ATC group C071AZUR-21Aalen University1Agogo Presbyterian Hospital1Albany Medical College1Aliment Pharmacol Ther1Allegheny Health1AllofUS1Alomone Labs1American Dental Association1American Journal of Gastroenterology1American Society of Transplantation1Amiens-Picardie University Hospital1Aneuvas Technologies, Inc1Archambault et al1Arm 31Asociación Latinoamericana para el Estudio del Hígado1AstraZeneca1Atrium Health Carolinas Medical Center1BD Biosciences1BE MOBILE 11BIDMC1BIOME study1BMHI1BSGE1BSU1BabyGel trial1Baxter et al1Beijing1Beijing Friendship Hospital1Beijing Huilongguan Hospital1Benchmark-SLE1BioMedware1BioMere1BornFyne1Boston University Medical Center1Brain Aneurysm Foundation1Brain-Heart team1Brightline1Bristol Myers Squibb1British Menopause Society1BronchUK Registry1Brown University Health Institutional Review Board1C-STACS1CAMP1CANN20211CASEM1
Articles mentioning institutions
11,350 articles · page 612 of 946NCT03978520COVID-19upadacitinibPBOUPASLESLEek
…bjective of this post hoc analysis of the phase 2 SLEek study ( NCT03978520) was to evaluate the achievement of LLDAS and DORIS with upadac…
NCT03742037cenerimodautoimmune diseaseSLEsystemic lupus erythematosusLupus
…eutic benefits in autoimmune disease. The Phase 2b CARE study ( NCT03742037) evaluated the efficacy and safety of cenerimod at doses 0.5, 1…
CSTARBelimumabTofacitinibSLESystemic lupus erythematosusTOFBEL
…study based on the Chinese SLE Treatment and Research Registry (CSTAR). Maintenance therapy was defined as treatment after achieving …
Bioplex 2000SLESLE-preventionSLE-relatedRo52
…ies to an at-risk cohort.Methods ANA+ individuals identified by Bioplex 2000 were referred to secondary care with non-specific symptoms but …
UK DEFINITION Cohort C studySLEinterferonIFNIFN-highpSSUCTDSScIIMMCTD+2 more
… multiple ANA-RMDs.Methods Adults with ANA-RMDs enrolled in the UK DEFINITION Cohort C study were reviewed at baseline, 3 and 6 months. Clinical outcomes in…
Taichung Veterans General HospitalSystemic lupus erythematosusSLESLE-PRS
…Methods From the Taiwan Precision Medicine Initiative cohort at Taichung Veterans General Hospital, 129 individuals in the top 5% of SLE polygenic risk scores (PR…
University College London HospitalprednisoloneSLELupusSLEDAI-2KSLEDAI-LLDAS
…tment and laboratory data from 607 individual patients from the University College London Hospital SLE Cohort (2011-2024) were used to determine BILAG-LLDAS and S…
PRECISESADS projectsystemic lupus erythematosusSLEsystemic sclerosisSjDSScSLE-associatedSjögren’s disease
…ntibody levels were analysed in genotyped participants from the PRECISESADS project (n=638). Positivity thresholds were defined per antigen using t…
University HospitalsCyclophosphamideLupus NephritisSLECycLN induction treatment
…RS data, and available clinical information were recruited from University Hospitals in Uppsala, Linköping and Stockholm, Sweden. Patients were geno…
NCT04294667dapirolizumab pegolDZPBILAG-2004prednisone
…lare frequency, using data from the phase 3 PHOENYCS GO trial ( NCT04294667) of dapirolizumab pegol (DZP).DZP, a novel CD40L inhibitor, con…